Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2025-12-25 @ 3:43 AM
NCT ID:
NCT02360202
Eligibility Criteria:
Inclusion Criteria:
* Patient with age higher than 18
* Patient with bullous pemphigoid,
* Patient treated by local corticosteroid therapy (clobetasol propionate cream) but not yet processed or for less than 48 hours,
* Signed informed consent.
* Patient affiliated to Social Security Regimen
* Effective contraception in women of childbearing age (for postmenopausal women, confirmatory diagnosis of menopause will be collected)
Exclusion Criteria:
* Concomitant treatment with corticosteroids
* Recent introduction or recent (\<6 weeks) treatment with diuretics, angiotensin-converting enzyme, receptor antagonist or anti-angiotensin renin (aliskiren)
* contraindication to the use of Clobetasol propionate (DERMOVAL and CLARELUX)
* Patient on salt diet (\<or = to 5 g / d)
* Patients carry a defibrillator or a pace maker
* Amputated Patient
* Pregnant and lactating
* Patient with Urinary Incontinency
* Recent heart decompensation in the last 6 weeks
* known Nephrotic Syndrome
* known or Severe hepatic impairment
* Hypoalbuminaemia less than 20 g / l
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02360202
Study Brief:
Protocol Section:
NCT02360202